Exclusive: Catalent to expand production of J&J COVID-19 vaccine in Italy: WSJ

(Reuters) – Catalent Inc plans to expand its COVID-19 vaccine production in Europe that will enable it to make more doses of Johnson & Johnson’s shot, the Wall Street Journal reported here on Tuesday, citing people familiar with the matter.

The contract drug manufacturer will bring online a second J&J vaccine production line at its plant in Anagni, Italy, during the fourth quarter, the Journal reported.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.